Exercise for Type 2 Diabetes
(GUTFIT Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to explore how different types of exercise impact people with type 2 diabetes. Participants will engage in either moderate or high-intensity endurance and strength training for 16 weeks as part of a Combined Exercise Intervention. Researchers will compare these exercise routines to assess their effects on blood sugar levels and gut bacteria diversity. People with type 2 diabetes who aren't currently very active and have stable medication routines might be a good fit for this trial.
As an unphased trial, this study offers participants the opportunity to contribute to valuable research that could enhance exercise recommendations for managing type 2 diabetes.
Will I have to stop taking my current medications?
The trial does not specify if you need to stop taking your current medications. However, you must not have changed your diabetes medications in the last three months to be eligible.
What prior data suggests that this exercise intervention is safe for individuals with type 2 diabetes?
Research has shown that high-intensity interval training (HIIT) is generally safe for people with type 2 diabetes. One study found that a specific HIIT routine, which includes short bursts of intense activity, was effective and well-tolerated. It improved blood sugar control and heart and lung fitness without causing significant side effects. Another study confirmed these results, showing similar improvements in blood sugar management and body composition over eight weeks.
Moderate-intensity exercise is also commonly recommended for those with type 2 diabetes. Regular moderate exercise has been shown to lower blood sugar levels, improve insulin use, and reduce blood pressure. It is considered safe and beneficial, with guidelines suggesting at least 150 minutes per week.
Both high-intensity and moderate-intensity exercises have proven safe and effective for managing type 2 diabetes. Participants in studies handled these exercises well, and no major safety issues were reported.12345Why are researchers excited about this trial?
Researchers are excited about this trial because it explores how different intensities of exercise can help manage Type 2 Diabetes, potentially offering a natural and cost-effective alternative to medication. Unlike standard treatments that rely heavily on drugs to control blood sugar levels, this approach focuses on high-intensity and moderate-intensity aerobic and strength training exercises to improve insulin sensitivity and overall metabolic health. By comparing these two intensities, the trial aims to find out which is more effective, paving the way for personalized exercise recommendations as a primary strategy for diabetes management.
What evidence suggests that this trial's exercise interventions could be effective for type 2 diabetes?
Research has shown that combining different types of exercise can greatly benefit people with type 2 diabetes. Studies indicate that it helps control blood sugar, aids in weight loss, and enhances the body's use of insulin, thereby managing blood sugar levels more effectively. Exercise also improves cholesterol and overall health. In this trial, participants will follow different exercise regimens. Some will perform high-intensity aerobic and strength training exercises, while others will engage in moderate-intensity exercises. Some research suggests that high-intensity exercise can be as effective as moderate-intensity exercise for improving blood sugar and fat levels. Overall, regular combined exercise offers a promising way to support better health in type 2 diabetes.678910
Who Is on the Research Team?
Martin Senechal, Ph.D.
Principal Investigator
University of New Brunswick
Are You a Good Fit for This Trial?
Adults aged 19-64 with type 2 diabetes, not very active (less than 10,000 steps per day), stable on their current diabetes medications for the last three months, and have an HbA1c level of at least 7.5%. They should also be falling short of recommended physical activity levels.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants undergo a supervised exercise intervention of resistance and aerobic training for 16 weeks, performed at either high or moderate intensity
Follow-up
Participants are monitored for changes in glycemic control and gut microbiome diversity after the intervention
What Are the Treatments Tested in This Trial?
Interventions
- Combined Exercise Intervention
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of New Brunswick
Lead Sponsor
Laval University
Collaborator